Noelle Baquiche

Yiannis Kiachopoulos

Angeliki Andrianopoulou

Magdalena Sommenvik

Artur Saudabayev

Causaly AI has performed a network analysis of the 40,000 COVID-19 full text papers recently made public as part of CORD-19, in addition to 30 million existing biomedical publications.

COVID19: Causaly AI releases Top 250 compounds for further research

COVID-19: Causaly AI releases Top 250 compounds for further research following CORD-19 Network Analysis

We used Causaly to identify 42 substances, which like Chloroquine act on the ACE2 gene, and have potential to be re-purposed to treat COVID-19.

Beyond Chloroquine: AI helps identify possible treatments for COVID-19

We used Causaly to identify these 42 substances, which like Chloroquine act on the ACE2 gene, and have potential to be re-purposed to treat COVID-19.

We used Causaly AI to identify 42 existing compounds with potential to be re-purposed to treat COVID-19.

Teaching computers how to read and understand biomedical publications for cause and effect relationships is a challenging task. This is especially true for it might not be intuitive what we mean by "read" and "understand".

Not all evidence is created equal: Machine-Reading in Biomedicine

The underlying query machine-reads 143,548 articles within < 2 seconds and returns 53 hormones as potential mediators for the relationship (Obesity)->(Breast Cancer).

How is Obesity related to Breast Cancer? Insights from 140,000 articles.

Rapid search for causes of anxiety at super human speed using the Causaly machine-reading platform

How to read 35,000 articles in 1 minute

Causaly Inc., an AI for Biomedical cause & effect discovery, announces today the completion of a $1m seed round led by Marathon Venture Capital.

Causaly Raises $1 Million Seed Round to Deliver AI for Cause & Effect Discovery in Biomedicine

Having an understanding of how the world ticks is at the core of developing our hypotheses. We are connecting the dots from millions of documents into causal knowledge graphs.

Featured article

COVID-19: Causaly AI releases Top 250 compounds for further research following CORD-19 Network Analysis

Posts written by Yiannis Kiachopoulos

Sign up for Causaly newsletter